WCN26-7941 THE IMPACT OF COMPREHENSIVE MEDICATION MANAGEMENT ON CLINICAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE

Read full text Summarise with VIRAT
Authors: Helena Orehovački, Mateja Kuljanac, Lucija Ana Bićanić, Andrea Brajković, Ivana Gudelj, Ingrid Prkačin, Lorena Bosnar, Domagoj Kifer, Iva Mucalo
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Over the past decade, growing medication complexity and costs have highlighted the importance of systematic drug optimization. Comprehensive medication management (CMM) focuses on individualized assessment of all patient medications for appropriateness, effectiveness, safety, and adherence. This approach could be valuable for patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD), where precise management reduces the risk of disease progression and complications. This study primarily aims to examine the impact of CMM on relevant clinical outcomes in T2D and CKD (systolic blood pressure (SBP), LDL, HbA1c).

Fields of Study & Subjects

Pharmaceutical Practices and Patient Outcomes Chronic Kidney Disease and Diabetes Diabetes Treatment and Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104646–104646
Publication date
25 March 2026
Language
EN